890 assets in Neoplasm

Therapeutic assets addressing Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
abl103 Neoplasm	ABL Bio, Inc.	P1/2	CC (41)
Acit-1 Neoplasm	Cancer Vaccines Limited	P1/2	CC (41)
asp0739 Neoplasm	Astellas Pharma Global Development, Inc.	P1/2	CC (41)
Atirmociclib Neoplasm	Pfizer	P1/2	CC (41)
Belantamab Mafodotin Neoplasm	Hellenic Society of Hematology	P1/2	CC (41)
bi-1910 Neoplasm	BioInvent International AB	P1/2	CC (41)
cts2190 capsules Neoplasm	CytosinLab Therapeutics Co., Ltd.	P1/2	CC (41)
Dcsz11 Neoplasm	West China Hospital	P1/2	CC (41)
f520 Neoplasm	Shandong New Time Pharmaceutical Co., LTD	P1/2	CC (41)
gsk4524101 Neoplasm	GlaxoSmithKline	P1/2	CC (41)
gsk5460025 Neoplasm	GlaxoSmithKline	P1/2	CC (41)
hb0052 Neoplasm	Shanghai Huaota Biopharmaceutical Co., Ltd.	P1/2	CC (41)
Hrs-4642 Neoplasm	Henan Cancer Hospital	P1/2	CC (41)
htl0039732 capsules Neoplasm	Cancer Research UK	P1/2	CC (41)
Human Leukocyte Neoplasm	Dipnarine Maharaj	P1/2	CC (41)
Icp-723 Neoplasm	Beijing InnoCare Pharma Tech Co., Ltd.	P1/2	CC (41)
Incb177054 Neoplasm	Incyte Corporation	P1/2	CC (41)
Inv-1120 Neoplasm	Shenzhen Ionova Life Sciences Co., Ltd.	P1	CC (41)
Ivonescimab Neoplasm	GlaxoSmithKline	P1/2	CC (41)
Jab-2485 Neoplasm	Jacobio Pharmaceuticals Co., Ltd.	P1/2	CC (41)
Jab-30355 Neoplasm	Jacobio Pharmaceuticals Co., Ltd.	P1/2	CC (41)
kd-496 Neoplasm	Peking University	P1	CC (41)
Nenocorilant Neoplasm	Corcept Therapeutics	P1/2	CC (41)
Ntx-1088 Neoplasm	Nectin Therapeutics Ltd	P1	CC (41)
NW-301D Neoplasm	Peking University	P1	CC (41)
nw-301v Neoplasm	Peking University	P1	CC (41)
Onm-501 Neoplasm	OncoNano Medicine, Inc.	P1	CC (41)
Panax Ginseng Neoplasm	M.D. Anderson Cancer Center	P1/2	CC (41)
Personalized Neoantigen Peptide Vaccine Neoplasm	Seqker Biosciences, Inc.	P1/2	CC (41)
Pimasertib Neoplasm	Day One Biopharmaceuticals, Inc.	P1	CC (41)
rc278 Neoplasm	RemeGen Co., Ltd.	P1/2	CC (41)
rd13-02 cell infusion Neoplasm	Kai Lin Xu，MD	Early P1	CC (41)
Revumenib Neoplasm	Syndax Pharmaceuticals	P1/2	CC (41)
Rgl-270 Neoplasm	Xian-Jun Yu	P1	CC (41)
s-531011 Neoplasm	Shionogi	P1/2	CC (41)
Shr-4375 Neoplasm	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	P1/2	CC (41)
Shr-4610 Neoplasm	Shanghai Shengdi Pharmaceutical Co., Ltd	P1/2	CC (41)
Shr-A2102 Neoplasm	Henan Cancer Hospital	P1/2	CC (41)
soa101 Neoplasm	Shine-On Biomedical Co., Ltd.	P1/2	CC (41)
Sulfur Hexafluoride Neoplasm	NaviFUS Corporation	P1/2	CC (41)
Tak-853 Neoplasm	Takeda	P1/2	CC (41)
Tcr-T Cells Neoplasm	Sun Yat-sen University	P1	CC (41)
Tegtociclib Neoplasm	Pfizer	P1/2	CC (41)
Tobemstomig Neoplasm	Hoffmann-La Roche	P1/2	CC (41)
ty-1091 Neoplasm	TYK Medicines, Inc	P1/2	CC (41)
vb15010 Neoplasm	Zhejiang Yangli Pharmaceutical Technology Co., Ltd.	P1/2	CC (41)
White Blood Cells/Granulocytes Neoplasm	Dipnarine Maharaj	P1/2	CC (41)
zl-1310 Neoplasm	Zai Lab (Shanghai) Co., Ltd.	P1/2	CC (41)
177lu-fap-2286 Neoplasm	Novartis Pharmaceuticals	P1/2	CC (40)
[177lu]lu-sn201 Neoplasm	Spago Nanomedical AB	P1/2	CC (40)

Showing 351 to 400 of 889 assets

PreviousPage 8 of 18Next